Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors
US8450322B2 · kind B2 · utility
66Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2009 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Sep 21, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I): in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.